logo
Best money market account rates today, June 9, 2025 (Earn up to 4.41% APY)

Best money market account rates today, June 9, 2025 (Earn up to 4.41% APY)

Yahooa day ago

Find out which banks are offering the top rates. Money market accounts (MMAs) can be a great place to store your cash if you're looking for a relatively high interest rate along with liquidity and flexibility.
Unlike traditional savings accounts, MMAs typically offer better returns, and they may also provide check-writing privileges and debit card access. This makes these accounts ideal for holding long-term savings that you want to grow over time, but can still access when needed for certain purchases or bills.
Even though rates have been falling over the past several months, it's still possible to find money market accounts that pay more than 4% APY.
Here is a look at some of today's best money market account rates:
Interested in earning the best possible interest rate on your savings balance? Here is a look at some of the best savings and money market account rates available today from our verified partners.
This embedded content is not available in your region.
Money market account rates have fluctuated significantly in recent years, largely due to changes in the Federal Reserve's target interest rate.
In the wake of the 2008 financial crisis, for example, interest rates were kept extremely low to stimulate the economy. The Fed slashed the federal funds rate to near zero, which led to very low MMA rates. During this time, money market account rates were typically around 0.10% to 0.50%, with many accounts offering rates on the lower end of that range.
Eventually, the Fed began raising interest rates gradually as the economy improved. This led to higher yields on savings products, including MMAs. However, in 2020, the COVID-19 pandemic led to a brief but sharp recession, and the Fed once again cut its benchmark rate to near zero to combat the economic fallout. This resulted in a sharp decline in MMA rates.
But starting in 2022, the Fed embarked on a series of aggressive interest rate hikes to combat inflation. This led to historically high deposit rates across the board. By late 2023, money market account rates had risen substantially, with many accounts offering 4% or higher. However, the Fed finally began cutting rates in late 2024.
As of 2025, MMA rates remain high by historical standards, though they've begun a downward trajectory following the Fed's most recent rate cuts. Today, online banks and credit unions tend to offer the highest rates.
When comparing money market accounts, it's important to look beyond just the interest rate. Other factors, such as minimum balance requirements, fees, and withdrawal limits, can impact the total value you get from the account.
For example, it's common for money market accounts to require a large minimum balance in order to earn the highest advertised rate — as much as $5,000 or more in some cases. Other accounts may charge monthly maintenance fees that can eat into your interest earnings.
However, there are several MMAs available that offer competitive rates without any balance requirements, fees, or other restrictions. That's why it's important to shop around and compare accounts before making a decision.
Additionally, ensure that the account you choose is insured by the Federal Deposit Insurance Corporation (FDIC) or the National Credit Union Administration (NCUA), which guarantees deposits up to $250,000 per institution, per depositor. Most money market accounts are federally insured, but it's important to double-check in the rare case the financial insitution fails.
Read more: Money market account vs. high-yield savings account: Which is best for you?
The national average interest rate for money market accounts is just 0.64%, according to the FDIC. However, the best money market account rates often pay around 4% to 4.50% APY — similar to the rates offered on high-yield savings accounts.
The amount you will earn on $50,000 in a money market account depends on the annual percentage rate (APY) and the time period you leave the money in the account. For example, if you deposit $50,000 into a money market account that pays 4.5% APY and left it in your account for one year, you'd earn $2,303 in interest.
There are currently no money market accounts that pay 5% APY. However, some high-yield savings accounts from online banks do. You can also check with your local bank or credit union to find out if they offer a 5% APY account that fits your needs.
This embedded content is not available in your region.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

'I'm 53, $50K in Debt, and I Want a Divorce': Truck Driver Tells Dave Ramsey He Has Nothing Saved And Owes IRS — 'You're in a Jar of Pickles'
'I'm 53, $50K in Debt, and I Want a Divorce': Truck Driver Tells Dave Ramsey He Has Nothing Saved And Owes IRS — 'You're in a Jar of Pickles'

Yahoo

time38 minutes ago

  • Yahoo

'I'm 53, $50K in Debt, and I Want a Divorce': Truck Driver Tells Dave Ramsey He Has Nothing Saved And Owes IRS — 'You're in a Jar of Pickles'

At 53, Donnie from Fayetteville, North Carolina, called into "The Ramsey Show" with a brutally honest update: "I'm 53, have nothing for retirement, $50,000 in debt, and want a divorce." That was the actual title of the episode — and pretty much the entire plot. A truck driver with decades on the road, Donnie laid out his financial and emotional dead ends in one breath, prompting Dave Ramsey and co-host John Delony to react with a mix of concern, tough love and a few chuckles at the sheer weight of it all. "Man, it's an honor to talk to you," Donnie began optimistically. "Dave, I'm in a pickle." Don't Miss: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — 'Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. That's putting it mildly. "I'm 53 years old, have absolutely nothing for retirement, I'm $50,000 in debt... and I want a divorce," he confessed in one breath. "Sounds like you're in a jar of pickles," Ramsey quipped. The trouble started slowly, Donnie said. After 32 years of marriage, things had been slipping — both emotionally and financially. As an over-the-road trucker, Donnie spent most of his time on the highway while his wife handled the finances back home. "We were doing great," he recalled. "COVID hit, I was home. We got debt free, paid off everything we had. I had six months of living expenses saved up." Then things swerved. "She just got a wild hair up her britches," Donnie said, "wanted to move into a house and doubled our rent. Emptied the savings. Then she got crazy and went and got all these credit cards." Trending: Maximize saving for your retirement and cut down on taxes: . And just when it seemed like things couldn't get worse, they did. "I found out I'm $30,000 in debt to the IRS for years of taxes that she didn't pay," he added. "I guess I should've been a little more on top of it." Ramsey didn't sugarcoat it. "You didn't achieve y'all's goal. You achieved your goal," he said. "She got debt-free for you." The lack of financial alignment — and communication — was obvious. Donnie admitted he had introduced his wife to Ramsey's famous "debt snowball" method and pushed hard for a financial overhaul. "I just sort of put my foot down and said, 'Look, this is the way it's gotta be,'" Donnie said. But Ramsey wasn't impressed with the forceful approach: "You stomped on her toes... you didn't really do anything." Delony added, "You've been doing the dance of the victim. 'She did this to me.' 'He left me.' That dance keeps you stuck."Despite their financial success during the pandemic, the marriage kept unraveling. Donnie described himself as being in "full panic mode" since turning 50. Still, he showed up to the call with humility and humor, asking for a clear path forward. "My biggest issue right now is figuring out what to do about these taxes," he said. Ramsey offered a starting point, advising Donnie to connect with a qualified tax professional who could help him negotiate a payment plan with the IRS. But he warned Donnie — without alignment in the marriage, financial recovery might not mean much. "You're going to continue to have financial problems as long as you're not communicating and aligned," Ramsey said. "Aligned doesn't mean demanding. It means we both see the same future and both agree on how to get there." The message was clear: no amount of money will fix a relationship built on miscommunication, mistrust, and misaligned goals. If Donnie can't get his wife back on the same team, Ramsey added bluntly, "You are divorced. And then you get to go fix your money problems." Feeling stuck like Donnie? You're not alone. If you're staring down $0 in retirement, mountains of debt, or financial betrayal, all hope is not lost. A licensed financial advisor or tax professional can help you make sense of the mess and create a plan that actually sticks. And if your relationship is part of the problem, it might be time to have the hard conversations — together. Even when you're "in a jar of pickles," there's a lid... and a way out. Read Next:Deloitte's fastest-growing software company partners with Amazon, Walmart & Target – Image: Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article 'I'm 53, $50K in Debt, and I Want a Divorce': Truck Driver Tells Dave Ramsey He Has Nothing Saved And Owes IRS — 'You're in a Jar of Pickles' originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Multi-Blood Monitoring System Market is expected to reach USD 3.9 billion by 2034, with a 6.4% CAGR growth
Multi-Blood Monitoring System Market is expected to reach USD 3.9 billion by 2034, with a 6.4% CAGR growth

Yahoo

time38 minutes ago

  • Yahoo

Multi-Blood Monitoring System Market is expected to reach USD 3.9 billion by 2034, with a 6.4% CAGR growth

Multi Blood Monitoring System Market Overview 2025-2034 Luton, Bedfordshire, United Kingdom, June 10, 2025 (GLOBE NEWSWIRE) -- The global multi blood monitoring system market is witnessing dynamic expansion, with its value estimated at approximately USD 2.1 billion in 2024, and expected to grow to around USD 3.9 billion by 2034. This translates into a Compound Annual Growth Rate (CAGR) of 6.4% over the forecast period from 2025 to 2034. This growth is primarily fueled by the increasing demand for accurate, efficient, and accessible blood monitoring technologies across various healthcare applications. Download PDF Brochure: These devices are critical in the management of chronic diseases such as diabetes and cardiovascular conditions. As the global burden of such illnesses escalates, particularly among aging populations and across developing regions, the need for real-time, portable, and user-friendly blood monitoring systems has become more urgent than ever. Market Drivers and Opportunities Several underlying factors are contributing to the expansion of this market. Among the most significant drivers is the rising prevalence of chronic diseases. The World Health Organization (WHO) forecasts that by 2030, chronic diseases will account for over 75% of global deaths, highlighting the growing necessity for continuous and reliable health monitoring tools. Moreover, technological advancements in wearable devices, mobile health apps, and telemedicine have revolutionized the way blood monitoring is conducted. These innovations have led to more personalized and preventive healthcare solutions, allowing patients to self-monitor in real-time, often without the need for clinical supervision. This trend is particularly appealing to tech-savvy consumers and younger demographics who are increasingly proactive about their health. Emerging economies also present significant growth potential. With rising healthcare expenditure, expanding middle-class populations, and improving medical infrastructure, regions such as Asia-Pacific, Latin America, and parts of the Middle East are becoming fertile grounds for market expansion. Additionally, the integration of AI and machine learning into monitoring systems is creating opportunities for predictive diagnostics and tailored treatment strategies, revolutionizing the future of personalized medicine. Key Market Challenges Despite its positive growth outlook, the multi blood monitoring system market faces certain challenges. One of the primary obstacles is the complex regulatory landscape. Medical device manufacturers must navigate stringent approval processes, especially in developed regions like North America and Europe. These regulations, although necessary for ensuring safety and efficacy, often delay product rollouts and increase development costs. Supply chain disruptions have also impacted the market, particularly during and after the COVID-19 pandemic. Delays in procuring raw materials, component shortages, and transportation hurdles have affected production timelines and product availability. Furthermore, high costs associated with technologically advanced blood monitoring devices can be a deterrent for adoption, especially in price-sensitive markets. Healthcare providers are often pressured to deliver cost-effective solutions, which can limit investments in premium monitoring systems. Another pressing concern is data security and patient privacy. With the growing digitalization of healthcare and increased reliance on cloud-based data storage, ensuring the protection of sensitive patient information has become paramount. Regulatory frameworks such as HIPAA and GDPR are placing additional burdens on companies to fortify their cybersecurity measures. Market Segmentation Analysis By Product Type The market is segmented into several product categories including continuous glucose monitoring (CGM) systems, blood pressure monitors, cholesterol testing devices, and complete blood count (CBC) test devices. Among these, CGM systems are emerging as the dominant product category, accounting for roughly 35% of market share. The increased prevalence of diabetes globally has significantly contributed to this trend. Blood pressure monitoring devices come in second, capturing an estimated 25% of the market, owing to the widespread incidence of hypertension. Cholesterol testing devices follow with a 15% market share, as more individuals become aware of the risks associated with high cholesterol levels. By End User Hospitals are the largest consumers of multi blood monitoring systems, accounting for nearly 45% of the market share. The growing number of patients and a strong focus on preventive healthcare are driving demand in this segment. Diagnostic laboratories represent the second-largest user group, contributing 30% of market revenue, largely due to the complexity and volume of testing they handle. Homecare settings have gained traction, especially post-pandemic, and currently hold around 20% of the market. The convenience of remote monitoring has been widely appreciated, particularly among the elderly and chronically ill patients who prefer in-home testing. By Technology From a technology standpoint, wearable technologies are transforming the landscape, projected to represent 40% of the market by 2034. These devices offer unmatched convenience and user engagement. Invasive technologies still maintain a solid 45% market share, particularly in clinical environments where precision is critical. Meanwhile, non-invasive technologies are growing steadily and are expected to hold 15% of the market, driven by advancements in optical and sensor-based innovations. By Application Diabetes management remains the top application area, constituting about 50% of the total market. As diabetes rates continue to climb worldwide, the demand for continuous and accurate glucose monitoring devices is increasing proportionally. Cardiovascular monitoring is another important application, making up 30% of the market, while fitness and wellness monitoring is growing rapidly, accounting for around 15% as consumers adopt proactive health strategies. By Distribution Channel In terms of distribution, offline sales still dominate with a 55% market share, primarily due to the preference for in-person consultations and product demonstrations in hospital and clinical settings. Online channels, however, are growing fast and now represent 30% of sales, fueled by digital adoption and e-commerce growth. Direct sales—through specialized distributors—comprise the remaining 15%, ensuring product customization and support services. Browse full Report - Market Segmentation Product Type - Continuous Glucose Monitoring Systems - Blood Pressure Monitoring Devices - Cholesterol Testing Devices - Complete Blood Count Test Devices - Others End-User - Hospitals - Diagnostic Laboratories - Homecare Settings - Research Institutions Technology - Wearable Technology - Non-invasive Technology - Invasive Technology Application - Diabetes Management - Cardiovascular Monitoring - Blood Disorders Management - Fitness and Wellness Monitoring Distribution Channel - Online Sales - Offline Sales - Direct Sales Region - North America - Europe - Asia Pacific - Latin America - Middle East & Africa Regional Outlook Regionally, North America leads the global market, accounting for approximately 40% of total revenues in 2024. This dominance is attributed to advanced healthcare infrastructure, favorable regulatory support, and the presence of leading industry players. Europe follows with a 30% market share, supported by robust public healthcare systems and a rising focus on personalized medicine. The Asia-Pacific region is the fastest-growing market, projected to expand at a CAGR of 7.5%. This growth is driven by large patient populations, increasing disposable income, and government initiatives to enhance healthcare access. Countries such as China, India, and Japan are key contributors to this growth trajectory. Latin America and the Middle East & Africa collectively account for a modest share (5% in 2024) but are poised for steady growth due to improvements in healthcare infrastructure and expanding awareness about chronic disease management. Key Competitors Abbott Laboratories Roche Holding AG Siemens Healthineers Becton, Dickinson and Company (BD) Medtronic plc Nova Biomedical Johnson & Johnson Dexcom, Inc. Arkray, Inc. Ascensia Diabetes Care Terumo Corporation GlySens Incorporated Insulet Corporation Elysium Health LabCorp Recent Industry Developments Several companies have made notable strides in advancing this market: Abbott Laboratories launched FreeStyle Libre 3, a real-time glucose monitor with a discreet sensor, in June 2023, strengthening its lead in the CGM space. In April 2023, Roche formed a strategic partnership with a wearable tech firm to integrate blood monitoring devices with smart devices, enhancing patient engagement and adherence. Siemens Healthineers acquired an AI-based diagnostics company in August 2023, signaling a deeper focus on precision diagnostics through data analytics. Dexcom received FDA approval in September 2023 for a no-fingerstick CGM device, which is likely to broaden its user base and redefine market standards. Medtronic expanded its product line into Asia and Africa in July 2023, targeting underserved markets and accelerating growth in emerging economies. This report is also available in the following languages : Japanese (マルチ血液モニタリングシステム市場), Korean (다혈액 모니터링 시스템 시장), Chinese (多血液监测系统市场), French (Marché des systèmes de surveillance sanguine multi-sang), German (Markt für Multi-Blutüberwachungssysteme), and Italian (Mercato dei sistemi di monitoraggio multi-sangue), etc. Request Sample Pages: More Research Finding – Medical Refrigerated Market The global medical refrigerated market is valued at approximately $6.5 billion in 2024, with projections indicating a potential increase to around $10 billion by 2034. This growth reflects a robust Compound Annual Growth Rate (CAGR) of approximately 4.5% during the forecast period from 2025 to 2034. Cardiovascular Monitoring Devices Market The cardiovascular monitoring devices market is valued at approximately $10.5 billion in 2024, with projections indicating substantial growth, reaching around $16.8 billion by 2034. This translates to a robust Compound Annual Growth Rate (CAGR) of approximately 4.8% during the forecast period from 2025 to 2034. Non Invasive Hemodynamic Detection System Market The global Non-Invasive Hemodynamic Detection System market is valued at approximately USD 2.1 billion in 2024, with strong growth anticipated over the next decade. By 2034, the market is projected to reach around USD 4.5 billion, representing a Compound Annual Growth Rate (CAGR) of approximately 8.0%. Disposable Syringes and Accessories Market The global disposable syringes and accessories market is valued at approximately $7.5 billion in 2024, with a projected growth trajectory that anticipates reaching around $13 billion by 2034. This translates to a compound annual growth rate (CAGR) of about 6.1% over the 2025-2034 period. Blood Collection Mixer Market The blood collection mixer market is valued at approximately $250 million in 2024 and is projected to reach around $400 million by 2034. This growth represents a Compound Annual Growth Rate (CAGR) of about 5.1% during the forecast period from 2025 to 2034. Hemochromatosis Treatment Market The global hemochromatosis treatment market is valued at approximately $2.1 billion in 2024. The market is anticipated to grow significantly, reaching an estimated $3.5 billion by 2034, reflecting a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period of 2025–2034. Gestational Trophoblastic Disease Market The gestational trophoblastic disease (GTD) market is currently valued at approximately $1.8 billion in 2024, with projections indicating a potential growth to around $3.1 billion by 2034. This represents a compound annual growth rate (CAGR) of approximately 6.2% during the forecast period from 2025 to 2034. Septicemia Diagnostic Market The global septicemia diagnostics market is valued at approximately $1.5 billion in 2024, with projections indicating a growth to around $2.9 billion by 2034. This represents a Compound Annual Growth Rate (CAGR) of about 7.5% for the period from 2025 to 2034. Single Use Safety Lancet Market The global market for single-use safety lancets, valued at approximately $1.2 billion in 2024, is expected to reach around $2.5 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 7.7% during the forecast period from 2025 to 2034. Microalbuminuria Test Strip Market The microalbuminuria test strip market is poised for notable growth, valued at approximately $1.2 billion in 2024. This market is projected to expand to around $2.4 billion by 2034, indicating a robust growth trajectory. The Compound Annual Growth Rate (CAGR) for the forecast period from 2025 to 2034 is estimated at 7.3%. Monkeypox Virus Detection Reagent Market The monkeypox virus detection reagent market is anticipated to reach approximately $150 million in value by 2024, driven by heightened awareness and diagnostic needs amid ongoing public health surveillance. The market is projected to expand significantly, reaching an estimated $300 million by 2034, reflecting sustained interest in infectious disease diagnostics and preparedness. Blood Tester Market The global blood testing market is anticipated to reach a value of approximately $75 billion in 2024, driven by increasing prevalence of chronic diseases, rising health awareness, and advancements in diagnostic technologies. The market is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.5% from 2025 to 2034, potentially reaching over $135 billion by 2034. HBsAg ELISA Test Kit Market The HBsAg ELISA Test Kit market is poised for robust growth, with a current market value estimated at approximately $1.5 billion in 2024. Driven by the increasing global prevalence of Hepatitis B, ongoing advancements in diagnostic technologies, and rising healthcare expenditures, the market is projected to reach around $2.8 billion by 2034. This trajectory indicates a Compound Annual Growth Rate (CAGR) of approximately 6.5% from 2025 to 2034. Blood Plasma Extractor Market The global blood plasma extractor market is valued at approximately $1.2 billion, driven by rising demand for plasma-derived therapies in treating various diseases. The market is projected to reach about $2.9 billion by 2034, reflecting an impressive Compound Annual Growth Rate (CAGR) of approximately 9.2% from 2025 to 2034. Amphetamine Test Kit Market The amphetamine test kit market is projected to reach a value of approximately $500 million in 2024, with expectations to grow to around $900 million by 2034. This growth reflects a robust Compound Annual Growth Rate (CAGR) of 6% during the forecast period of 2025 to 2034. CONTACT: Irfan Tamboli (Head of Sales) Phone: + 1704 266 3234 Email: sales@ in to access your portfolio

Is a Recession Coming or Not? Here Are Both Sides of the Coin
Is a Recession Coming or Not? Here Are Both Sides of the Coin

Yahoo

timean hour ago

  • Yahoo

Is a Recession Coming or Not? Here Are Both Sides of the Coin

The debate over whether the U.S. is heading into a recession in 2025 is intensifying, with economists, policymakers and business leaders offering conflicting perspectives. While some indicators suggest an economic downturn is imminent, others point to resilience and potential for continued growth. Is a recession coming or not? Here are both sides of the coin. Trending Now: For You: According to Trading Economics, the U.S. economy contracted by 0.2% in the first quarter of 2025, marking the first decline since early 2022. In addition, a PNC Bank analysis found that consumer spending has also slowed to 0.3% after a 3.7% increase in March as consumers attempted to get ahead of anticipated tariffs. Check Out: President Trump's tariff policies have led to increased import costs, contributing to inflation and supply chain disruptions. The Organization for Economic Co-operation and Development (OECD), an international body that monitors global economic trends, has downgraded U.S. growth projections to 1.6% for 2025, citing these trade policies as a significant drag on the economy. At a recent meeting, Federal Reserve officials said the job market was anticipated to deteriorate significantly, with the unemployment rate projected to rise above the staff's estimate of its natural level by the end of this year and stay elevated beyond that natural rate until at least 2027. Additionally, CEO confidence has plummeted, with 83% predicting a recession within the next 12 to 18 months, according to a survey by The Conference Board, a non-profit research organization. The organization's Leading Economic Index (LEI) is widely used to predict the direction of the U.S. economy. According to J.P. Morgan data, the yield curve inversion, a traditional recession predictor, has persisted since July 2022. While its reliability is debated, the New York Fed's model estimates a 51% probability of a recession starting within a year, with a confidence interval ranging from 39% to 64%. Despite concerns, the labor market remains robust, with unemployment at 4.2% and continued job growth, according to data from the U.S. Bureau of Labor Statistics. Consumer spending, a key economic driver, has shown resilience, supporting the argument against an immediate recession. For example, data from the Washington Retail Association showed that in March, retail sales increased by 1.4%, driven by higher spending on cars, dining out and apparel. The Federal Reserve has maintained steady interest rates, balancing concerns over inflation and economic growth. 'The U.S. economy is still on a firm footing, but uncertainty has notably increased since the beginning of the year. In this environment, monetary policy will need to carefully balance our dual-mandate goals of price stability and maximum employment,' Federal Reserve Board Member Lisa Cook said at a recent meeting. Some economists suggest the U.S. may be experiencing a 'vibecession,' where negative public sentiment does not align with economic fundamentals, according to ClearBridge. This disconnect implies that while people feel pessimistic, the economy may not be in an actual recession. While official declarations of recession rely on two consecutive quarters of GDP decline, some economists argue that the reality of a downturn is already unfolding, both in data and in everyday life. 'Although there are still some economic sectors where activity remains and this may create the illusion of stability because the real situation remains tense,' said Julia Khandoshko, CEO of Mind Money. 'Everything that happens with debts and bonds exerts systemic pressure. Many people think that there is no recession until it is announced. This is a big mistake. In fact, when it is officially recognized, everything will be felt in the wallet for a long time,' Khandoshko explained. As uncertainty grows, Khandoshko said the smartest move is to prepare for a recession rather than trying to predict it. 'Think in advance how to reduce unnecessary expenses, postpone major purchases, try to reduce debts and form your safe haven,' she said. 'Because if everything goes according to a bad scenario, the speed at which the situation will change will be high.' Editor's note on political coverage: GOBankingRates is nonpartisan and strives to cover all aspects of the economy objectively and present balanced reports on politically focused finance stories. You can find more coverage of this topic on More From GOBankingRates 3 Luxury SUVs That Will Have Massive Price Drops in Summer 2025 The 5 Car Brands Named the Least Reliable of 2025 10 Unreliable SUVs To Stay Away From Buying This article originally appeared on Is a Recession Coming or Not? Here Are Both Sides of the Coin Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store